|
|
|
|
| Symbol(s): |
QCOR |
| Date: |
7-Feb-10 |
| Contributor: |
PriceTarget Research, Inc. |
| Title: |
QSC has a current Overall Rating of C (Neutral). |
| Document Size: |
7 pages |
| Price: |
$25 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $25. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| QSC has a current Overall Rating of C (Neutral). Appreciation potential (89) is very high; Power Rating (12) is very low. Relative to the S&P 500 Composite, Questcor Pharmaceuticals Inc has significant Growth characteristics -- its appeal is likely to be to Capital Gain-oriented investors. QCOR is of the highest investment quality. QSC's current technical position is neutral. QSC's Power Rating is 12. QSC's earnings estimates have fallen very significantly in recent months. QSC's...
| | |
|
|
